Medical Device Leader Series

Top Companion Diagnostics (CDx) Developers, Manufacturers and Marketers in 2016

LONDON, August 24, 2016 /PRNewswire/ --

Market Analysis and Company Profiles Including Abbott Laboratories, Myriad Genetics, Roche, Qiagen, Agilent Technologies, Siemens, Johnson & Johnson and Other Companies in the US, Europe, Israel, India, Canada and South Korea, Exploring Those Diagnostic Products for Personalised Medicine and Partnerships With Pharmaceutical Developers 

Companion Diagnostics - Discover Leading Companies' Activities and Outlooks
How are companies in the companion diagnostics (CDx) industry performing? Visiongain's new report gives you data, analysis and discussions for producers of those medical devices.

Our study lets you assess top companies in that industry and market, showing you their activities and outlooks. There you see financial results, opinion, trends, opportunities and revenue prediction for those developments in biomarkers, genomics, targeted therapies, theranostics and personalised medicine.

That way you explore the potentials of established and rising companies. Please read on to scan those 17 leading competitors and see what their future market could be worth.

Forecasts and discussions to help you stay ahead in knowledge and authority
Our new study assesses 17 leading companies and analyses that overall market. There you find sales results, revenue forecasting and growth rates. In our 166 page report you get 34 tables, 23 charts and an interview with MedGenome.

You also gain qualitative analyses, including discussion of research and development. Our work lets you assess the most beneficial and lucrative applications of those diagnostic tests for advancing human medicine, making it more personalised. Discover what is happening.

To see a report overview please email Sara Peerun on [e-mail]

Company profiles - see why firms succeed, also exploring their potentials
Our report profiles 17 leading companies worldwide. Our investigation discusses prominent companies, exploring their activities by:
• Analysing companion diagnostic product portfolios and technologies
• Investigating the status of commercial developments
• Assessing R&D and applications for those medical devices
• Uncovering organisations' strengths, weaknesses, activities, strategies and prospects
• Giving qualitative analyses and revenue forecasting of the overall world companion diagnostics market from 2016 to 2026.

Our survey shows you how technology changes, as well as explaining how diagnostic needs develop from 2016. Assess the rising demand for companion diagnostic products.